Literature DB >> 3986650

Intrapulmonary shunting during deliberate hypotension with nifedipine, diltiazem and labetalol in dogs.

P A Casthely, R Villanueva, L Rabinowitz, P Gandhi, B Litwak, P N Fyman.   

Abstract

Pulmonary shunt (Qs/Qt) was calculated in 49 mongrel dogs weighing 18-20 kg during mechanical ventilation, before and during deliberate hypotension with either nifedipine (group N), diltiazem (group D), labetalol (group L), or ethyl alcohol and polyethylene glycol (group E). A 30 per cent decrease in mean arterial blood pressure occurred after two minutes of nifedipine infusion, two minutes after diltiazem, and three minutes after labetalol; these effects lasted two hours after nifedipine administration, 90 minutes after diltiazem and three hours after labetalol. There was an accompanying significant decrease in systemic and pulmonary vascular resistance. Qs/Qt and cardiac output increased significantly after nifedipine infusion. Shunt increased (mean +/- S.E.) from 9.7 +/- 0.8 to 18.25 +/- 1.05 per cent at two minutes (p less than 0.0005); 19.05 +/- 1.2 per cent at 30 minutes (p less than 0.005); 17.5 +/- 1.6 per cent at two hours (p less than 0.01); and 12 +/- 1.1 per cent at three hours (p less than 0.025). No increase in shunt occurred after the administration of diltiazem, labetalol or polyethylene glycol and ethyl alcohol. Arterial oxygen tension (PaO2) decreased significantly after nifedipine infusion from 146 +/- 11.5 to 105 +/- 3.5 mmHg two minutes after infusion; to 89.5 +/- 3 mmHg 30 minutes after; 115 +/- 4.75 mmHg two hours after; and 130 +/- 10.75 mmHg three hours later. PaO2 was not significantly different after diltiazem, labetalol, or polyethylene glycol and ethyl alcohol administration. With nifedipine cardiac output increased from 2.25 +/- 0.3 to 3.95 +/- 0.25 after two minutes (p less than 0.005) to 3.85 +/- 0.35 after 30 minutes (p less than 0.005), 3.7 +/- 3 after two hours (p less than 0.01) to 2.9 +/- 1.1 after three hours. No significant increase in cardiac output occurred in groups D or L. These results suggest that only nifedipine infusion significantly alters oxygenation in dogs and therefore its use warrants caution in the presence of a preexisting abnormal Qs/Qt.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3986650     DOI: 10.1007/bf03010034

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  16 in total

1.  Hypoxia on the pulmonary circulation. How and where it acts.

Authors:  A P Fishman
Journal:  Circ Res       Date:  1976-04       Impact factor: 17.367

2.  Sodium nitroprusside increases Qs/Qt in dogs with regional atelectasis.

Authors:  P S Colley; F W Cheney
Journal:  Anesthesiology       Date:  1977-10       Impact factor: 7.892

3.  Hypoxic pulmonary vasoconstriction and infusion of sodium nitroprusside.

Authors:  J L Benumof
Journal:  Anesthesiology       Date:  1979-06       Impact factor: 7.892

4.  An improved program to calculate intrapulmonary shunting.

Authors:  D Siegel; S Ramanathan; J Chalon; H Turndorf
Journal:  Crit Care Med       Date:  1979-06       Impact factor: 7.598

5.  Effect of pulmonary vasoconstriction on balance between alveolar ventilation and perfusion.

Authors:  F Haas; E H Bergofsky
Journal:  J Appl Physiol       Date:  1968-04       Impact factor: 3.531

6.  Intracranial pressure during nifedipine-induced hypotension.

Authors:  J P Griffin; J E Cottrell; J Hartung; B Shwiry
Journal:  Anesth Analg       Date:  1983-12       Impact factor: 5.108

7.  Inhibition of hypoxic pulmonary vasoconstriction by nifedipine.

Authors:  G Simonneau; P Escourrou; P Duroux; A Lockhart
Journal:  N Engl J Med       Date:  1981-06-25       Impact factor: 91.245

8.  Inhibition of hypoxic pulmonary vasoconstriction by calcium antagonists in isolated rat lungs.

Authors:  I F McMurtry; A B Davidson; J T Reeves; R F Grover
Journal:  Circ Res       Date:  1976-02       Impact factor: 17.367

9.  Pulmonary shunting during anesthesia with deliberate hypotension.

Authors:  J G Stone; H J Khambatta; R S Matteo
Journal:  Anesthesiology       Date:  1976-11       Impact factor: 7.892

10.  Treatment of hypertension with nifedipine, a calcium antagonistic agent.

Authors:  M T Olivari; C Bartorelli; A Polese; C Fiorentini; P Moruzzi; M D Guazzi
Journal:  Circulation       Date:  1979-05       Impact factor: 29.690

View more
  8 in total

Review 1.  Calcium-channel blockers and anaesthesia.

Authors:  P G Durand; J J Lehot; P Foëx
Journal:  Can J Anaesth       Date:  1991-01       Impact factor: 5.063

2.  The influence of labetalol on arterial blood gas data, pulmonary haemodynamics and pulmonary shunting.

Authors:  S G De Hert; L G Heytens; R G De Jongh; M P Vercauteren; E A Boeckx; H F Adriaensen
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

3.  Influence of nimodipine and nifedipine on intrapulmonary shunting--a comparison to other vasoactive drugs.

Authors:  J Boldt; B Von Bormann; D Kling; K Ratthey; G Hempelmann
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

Review 4.  Controlled hypotension in children: a critical review of available agents.

Authors:  Joseph D Tobias
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

5.  Nimodipine: evidence for clinically significant gastrointestinal side-effects.

Authors:  E Hund; A Aschoff; V Tronnier; J Hampl; S Kunze
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

6.  Hypotensive actions of diltiazem and nitroprusside compared during fentanyl anaesthesia for total hip arthroplasty.

Authors:  J M Bernard; M Pinaud; S Carteau; C Hubert; R Souron
Journal:  Can Anaesth Soc J       Date:  1986-05

7.  The effect of nimodipine on pulmonary function in artificially ventilated patients with aneurysmal subarachnoid hemorrhage.

Authors:  Justyna Lunkiewicz; Giovanna Brandi; Jan Willms; Christian Strässle; Gagan Narula; Emanuela Keller; Carl Muroi
Journal:  Acta Neurochir (Wien)       Date:  2021-04-07       Impact factor: 2.216

8.  Clevidipine for perioperative blood pressure control in infants and children.

Authors:  Joseph D Tobias; David B Tulman; Sergio D Bergese
Journal:  Pharmaceuticals (Basel)       Date:  2013-01-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.